<qa>  What is the PHASE 3 STUDY TO COMPARE EFFICACY AND SAA PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF MASITINIB TO PLACEBO IN THE TREATMENT OF PATIENTS WITH SMOULDERING SYSTEMIC, INDOLENT SYSTEMIC OR CUTANEOUS MASTOCYTOSIS WITH HANDICAP: 